
BioCision has expanded its management team, appointing Hugh Douglas as chief operating officer and adding to its corporate advisory board. …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

